Opportunity for Pharmaceutical Enterprises
2012.12.24 08:19At present,our country has been the biggest API producer and exporter,the third pharmaceutical market and the second OTC pharmaceutical market of the world.Facing this opportunity,pharmaceutical enterprises are getting more and more confidence.
For now,the characteristic of pharmaceutical Industry in our country displayed as:API is the most competitive production,but lack of pharmaceutical production with high value-added.Meanwhile,there is no real large-scale enterprise in pharmaceuticals industry,and pharmaceutical enterprises also did not become a research subject.Along with the multinational enterprise increase investment scale in Chinese market,they have already monopolized the high-end pharmaceutical market. For the result of this situation,the development of our pharmaceutical enterprises will be further restricted.
"Market" and "policy" is becoming a opportunity for innovation of Chinese pharmaceutical enterprises.The demand of pharmaceutical market will increase in the next few years,especially before or after 2020.Otherwise,medical system reform is deepening and deepening,and support for new drug by government get more strengthened.At present,we have achieved the R&D industry chain which from drug discovery to clinical development to drug evaluation.
By Ricky